Preclinical Models of Autoimmune and Inflammatory Diseases

Symposium Time and Date

9:30am-3:30pm, Tuesday, October 27, 2009

Venue

Le Meridian hotel (formerly named MIT Hotel), 20 Sidney St, Cambridge MA

Contact
Rick Huntress, Opportunity Development Manager, The Jackson Laboratory, Ph: 1-781-733-4114

Registration
There is no charge to attend this event, but seating is limited. Please register your interest below to reserve a seat. Lunch and refreshments will be provided.

Program

9:00-9:30am Arrival and Coffee
9:30-9:45am
Yan Yang, Ph.D.
Business Unit Manager, JAX® In Vivo Services, The Jackson Laboratory
Opening Remarks
9:45-10:35am Dr. Carolyn Cuff,
Senior Group Leader, Department of Pharmacology, Abbott Bioresearch Center
Utilizing pre-clinical animal models as a tool to dissect the pathogenic mechanisms of asthma
10:40-11:30am
Ed Leiter, Ph.D.
Professor, The Jackson Laboratory
Comparison of two mouse models of IBD: C3H/HeJBir-IL10 Knockout and SAMP1/YitFc
11:35-12:30pm Stephen Laroux, Ph.D.
Director, Immunology and Inflammatory Diseases, Cequent Pharmaceuticals, Inc.
Experimental Models of IBD: Utility in Pre-Clinical Development
12:30-1:30pm Lunch
1:30-2:20pm Sha Mi, Ph.D.
Principle Investigator, Neuro-Discovery Biology, Biogen Idec
In Vivo Effects of Anti-LINGO on CNS Remyelination
2:25-3:15pm Martin Hegen, Ph.D.
Principal Research Scientist II, Inflammation Discovery Research, Wyeth
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis
3:15-3:30pm Leon Hall, Ph.D. 
Program Director, JAX® In Vivo Services, The Jackson Laboratory
Follow up questions and closing remarks

Registration form

We do not sell or rent personal information to third parties. Read our privacy policy for more information. We allow only corporate or university email addresses, we will not accept hotmail, yahoo, aol or similar email addresses.

* Designates required information

Salutation:


Sign Up for JAX® Mice News Email Newsletter (optional)

Learn about new JAX® Mice and Services when you subscribe to our email newsletter: